Pseudomonas aeruginosa utilizes host polyunsaturated phosphatidylethanolamines to trigger theft-ferroptosis in bronchial epithelium

Haider H. Dar, Yulia Y. Tyurina, Karolina Mikulska‐Ruminska(Nicolaus Copernicus University), Indira H. Shrivastava(VA Pittsburgh Healthcare System), Hsiu-Chi Ting, Vladimir A. Tyurin, James Krieger(VA Pittsburgh Healthcare System), Claudette M. St. Croix(Institute of Cell Biology), Simon C. Watkins(Institute of Cell Biology), Erkan Bayir, Gaowei Mao, Catherine R. Armbruster, Alexandr A. Kapralov, Hong Wang(University of Pittsburgh), Matthew R. Parsek(University of Washington), Tamil S. Anthonymuthu, Abiola F. Ogunsola, Becca A. Flitter, Cody J. Freedman(University of California, Santa Cruz), Jordan R. Gaston, Theodore R. Holman(University of California, Santa Cruz), Joseph M. Pilewski, Joel S. Greenberger(University of Pittsburgh), Rama K. Mallampalli(VA Pittsburgh Healthcare System), Yohei Doi, Janet Lee, İvet Bahar(VA Pittsburgh Healthcare System), Jennifer M. Bomberger, Hülya Bayır, Valerian E. Kagan(University of Pittsburgh)
Journal of Clinical Investigation
September 9, 2018
Cited by 241Open Access
Full Text

Abstract

Ferroptosis is a death program executed via selective oxidation of arachidonic acid-phosphatidylethanolamines (AA-PE) by 15-lipoxygenases. In mammalian cells and tissues, ferroptosis has been pathogenically associated with brain, kidney, and liver injury/diseases. We discovered that a prokaryotic bacterium, Pseudomonas aeruginosa, that does not contain AA-PE can express lipoxygenase (pLoxA), oxidize host AA-PE to 15-hydroperoxy-AA-PE (15-HOO-AA-PE), and trigger ferroptosis in human bronchial epithelial cells. Induction of ferroptosis by clinical P. aeruginosa isolates from patients with persistent lower respiratory tract infections was dependent on the level and enzymatic activity of pLoxA. Redox phospholipidomics revealed elevated levels of oxidized AA-PE in airway tissues from patients with cystic fibrosis (CF) but not with emphysema or CF without P. aeruginosa. We believe that the evolutionarily conserved mechanism of pLoxA-driven ferroptosis may represent a potential therapeutic target against P. aeruginosa-associated diseases such as CF and persistent lower respiratory tract infections.


Related Papers